Formycon AG has, with immediate effect, appointed Dr. Carsten Brockmeyer as its new Chief Executive Officer and member of its executive board. In recent years, Dr. Brockmeyer has advised clients through his own consulting company, Brockmeyer Biopharma. He is the author of more than 100 scientific publications and credited with a number of patented inventions.

His acclaimed work in the field of biopharmaceuticals has been recognized with prestigious scientific awards. Dr. Brockmeyer has more than 20 years of international experience in the areas of biopharmaceutical research and drug development, in the negotiation of licensing agreements and strategic alliances, and in the commercialization of new products. Having served on the company's advisory board, he already knows Formycon well, making him uniquely suited to step in as new CEO.